In vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.
Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign.
SeMPI 2.0-A Web Server for PKS and NRPS Predictions Combined with Metabolite Screening in Natural Product Databases.
High-Throughput CRISPR Screening Identifies Genes Involved in Macrophage Viability and Inflammatory Pathways.
Small molecule stabilization of non-native protein-protein interactions of SARS-CoV-2 N protein as a mechanism of action against COVID-19.
MNBDR: A Module Network Based Method for Drug Repositioning.
Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin.
Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.
Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.